190
Participants
Start Date
July 31, 2015
Primary Completion Date
January 31, 2019
Study Completion Date
January 31, 2019
AXS-02 (oral zoledronate)
Once weekly for 6 weeks
Placebo
Once weekly for 6 weeks
St. Marys
Orlando
Tucson
Hot Springs
Encinitas
La Jolla
Los Angeles
Napa
Temecula
Denver
Clermont
Miami
Tampa
West Palm Beach
Canton
Marietta
Meridian
Chicago
Louisville
Albuquerque
New York
Winston-Salem
Oklahoma City
Portland
Dallas
San Antonio
Bellevue
Seattle
Madison
Broadmeadow
Hurstville
Noosa
Welland
Clayton
Nedlands
Sherbrooke
Warrington
Darlington
Lambeth
Liverpool
Norwich
Newcastle upon Tyne
Glasgow
London
Lead Sponsor
Axsome Therapeutics, Inc.
INDUSTRY